Zimmermann WH - Search Results

1

3D engineered heart tissue for replacement therapy.

Eschenhagen T, Didié M, Münzel F, Schubert P, Schneiderbanger K, Zimmermann WH. Eschenhagen T, et al. Among authors: zimmermann wh. Basic Res Cardiol. 2002;97 Suppl 1:I146-52. doi: 10.1007/s003950200043. Basic Res Cardiol. 2002. PMID: 12479248

2

Three-dimensional reconstitution of embryonic cardiomyocytes in a collagen matrix: a new heart muscle model system.

Eschenhagen T, Fink C, Remmers U, Scholz H, Wattchow J, Weil J, Zimmermann W, Dohmen HH, Schäfer H, Bishopric N, Wakatsuki T, Elson EL. Eschenhagen T, et al. FASEB J. 1997 Jul;11(8):683-94. doi: 10.1096/fasebj.11.8.9240969. FASEB J. 1997. PMID: 9240969

3

Three-dimensional engineered heart tissue from neonatal rat cardiac myocytes.

Zimmermann WH, Fink C, Kralisch D, Remmers U, Weil J, Eschenhagen T. Zimmermann WH, et al. Biotechnol Bioeng. 2000 Apr 5;68(1):106-14. Biotechnol Bioeng. 2000. PMID: 10699878

4

Cardiac tissue engineering.

Eschenhagen T, Didié M, Heubach J, Ravens U, Zimmermann WH. Eschenhagen T, et al. Among authors: zimmermann wh. Transpl Immunol. 2002 May;9(2-4):315-21. doi: 10.1016/s0966-3274(02)00011-4. Transpl Immunol. 2002. PMID: 12180846 Review.

5

Cardiac grafting of engineered heart tissue in syngenic rats.

Zimmermann WH, Didié M, Wasmeier GH, Nixdorff U, Hess A, Melnychenko I, Boy O, Neuhuber WL, Weyand M, Eschenhagen T. Zimmermann WH, et al. Circulation. 2002 Sep 24;106(12 Suppl 1):I151-7. Circulation. 2002. PMID: 12354725

6

Cardiac tissue engineering for replacement therapy.

Zimmermann WH, Eschenhagen T. Zimmermann WH, et al. Heart Fail Rev. 2003 Jul;8(3):259-69. doi: 10.1023/a:1024725818835. Heart Fail Rev. 2003. PMID: 12878835 Review.

7

Heme oxygenase-1 and its reaction product, carbon monoxide, prevent inflammation-related apoptotic liver damage in mice.

Sass G, Soares MC, Yamashita K, Seyfried S, Zimmermann WH, Eschenhagen T, Kaczmarek E, Ritter T, Volk HD, Tiegs G. Sass G, et al. Among authors: zimmermann wh. Hepatology. 2003 Oct;38(4):909-18. doi: 10.1053/jhep.2003.50386. Hepatology. 2003. PMID: 14512878

8

Key role of myosin light chain (MLC) kinase-mediated MLC2a phosphorylation in the alpha 1-adrenergic positive inotropic effect in human atrium.

Grimm M, Haas P, Willipinski-Stapelfeldt B, Zimmermann WH, Rau T, Pantel K, Weyand M, Eschenhagen T. Grimm M, et al. Among authors: zimmermann wh. Cardiovasc Res. 2005 Jan 1;65(1):211-20. doi: 10.1016/j.cardiores.2004.09.019. Cardiovasc Res. 2005. PMID: 15621049

9

Endothelin-1 and isoprenaline co-stimulation causes contractile failure which is partially reversed by MEK inhibition.

Münzel F, Mühlhäuser U, Zimmermann WH, Didié M, Schneiderbanger K, Schubert P, Engmann S, Eschenhagen T, Zolk O. Münzel F, et al. Among authors: zimmermann wh. Cardiovasc Res. 2005 Dec 1;68(3):464-74. doi: 10.1016/j.cardiores.2005.06.020. Epub 2005 Jul 25. Cardiovasc Res. 2005. PMID: 16040022

10

Questioning the relevance of circulating cardiac progenitor cells in cardiac regeneration.

Zimmermann WH, Eschenhagen T. Zimmermann WH, et al. Cardiovasc Res. 2005 Dec 1;68(3):344-6. doi: 10.1016/j.cardiores.2005.09.010. Epub 2005 Oct 25. Cardiovasc Res. 2005. PMID: 16253213 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

197 results

Search Page

Filters